AQP4 and myeloid sarcoma: In a population based-study of patients with new-onset ON conducted in Olmsted County (Minnesota, United States), the frequency of MOGAD and AQP4-IgG+NMOSD ON were 5 and 3%, respectively; with MS (57%) and idiopathic ON (29%) being the most common final diagnoses (50).